THE COMPANY Polypure develops and manufactures monodisperse PEG derivatives for advanced technologies. Our quality standards ensure their successful use in research and industrial applications in nanotechnology, biotechnology and in pharmaceutical sciences. The compounds are produced by using a proprietary purification technology that is cost efficient and that can be readily scaled up to meet an increase in product demand. The company has been in operation since 1999. The business strategy relies on a focused product development to meet the demand for state of the art derivatives. We support the global market with our stock items, as well as custom synthesis products for specific applications. Our standard PEG catalogue products are distributed by major chemical distributors and are represented worldwide through agents in Europe, USA and Japan. Our strong market position serves a two-fold purpose, it allows us to be in a close dialogue with market needs and it generates revenues for a stable company growth. The major shareholders in the company are Erik Agner, co-founder and CEO of the Company, and Gamma Group AS, a firm engaged in high technology business development.
|